Rare childhood bone lymphoma: can past cases guide future care?
NCT ID NCT07721194
First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time
Summary
This study looks back at 21 children and teens diagnosed with a rare type of lymphoma that starts in the bone. Researchers are collecting medical records to describe how the disease presents, how it was treated, and how well patients did over time. The goal is to learn more about this uncommon cancer and help improve care for future patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- Better understanding of this rare childhood lymphoma could help standardize follow-up care and improve long-term outcomes.
- What could go wrong
- This is a small, retrospective review of past cases, not a controlled trial. Results may not apply to all patients or newer treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA, NON-HODGKIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU NICE
Nice, Alpes Maritimes, 06000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New pill targets Hard-to-Treat lymphoma in early human test
- Military study probes Toxins' role in lymphoma
- New transplant method aims to cut dangerous side effects in blood cancer patients
- Poop pills to prevent transplant rejection? new trial tests fecal transplants in blood cancer patients
- Supercharged immune cells aim to stop lymphoma comeback
- New hope for tough blood cancers: early trial of ONO-7018 begins